KalVista Pharmaceuticals Inc (KALV)
11.67
+0.42
(+3.73%)
USD |
NASDAQ |
May 31, 16:00
11.68
0.00 (0.00%)
After-Hours: 20:00
KalVista Pharmaceuticals Net Income (Quarterly): -29.03M for Jan. 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | -29.03M |
| October 31, 2023 | -27.65M |
| July 31, 2023 | -25.32M |
| April 30, 2023 | -26.30M |
| January 31, 2023 | -21.30M |
| October 31, 2022 | -22.26M |
| July 31, 2022 | -23.04M |
| April 30, 2022 | -24.11M |
| January 31, 2022 | -22.47M |
| October 31, 2021 | -19.65M |
| July 31, 2021 | -16.11M |
| April 30, 2021 | -14.96M |
| January 31, 2021 | -10.05M |
| October 31, 2020 | -10.43M |
| July 31, 2020 | -10.81M |
| April 30, 2020 | -6.584M |
| January 31, 2020 | -9.291M |
| October 31, 2019 | -5.903M |
| July 31, 2019 | -7.338M |
| April 30, 2019 | -8.526M |
| January 31, 2019 | -3.956M |
| Date | Value |
|---|---|
| October 31, 2018 | -3.304M |
| July 31, 2018 | -5.03M |
| April 30, 2018 | -0.657M |
| January 31, 2018 | -5.234M |
| October 31, 2017 | -4.986M |
| July 31, 2017 | -4.928M |
| April 30, 2017 | -4.202M |
| January 31, 2017 | -7.644M |
| September 30, 2016 | -2.385M |
| June 30, 2016 | -7.35M |
| March 31, 2016 | -6.607M |
| December 31, 2015 | -5.659M |
| September 30, 2015 | -4.991M |
| June 30, 2015 | -9.012M |
| March 31, 2015 | -5.184M |
| December 31, 2014 | -4.714M |
| September 30, 2014 | -3.995M |
| June 30, 2014 | -2.635M |
| March 31, 2014 | -2.015M |
| December 31, 2013 | -1.207M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-29.03M
Minimum
Jan 2024
-5.903M
Maximum
Oct 2019
-17.51M
Average
-19.65M
Median
Oct 2021
Net Income (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -12.28M |
| Electromed Inc | 1.493M |
| Xtant Medical Holdings Inc | -4.40M |
| Asensus Surgical Inc | -22.50M |
| Myomo Inc | -3.836M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 33.15M |
| EPS Diluted (Quarterly) | -0.84 |
| Enterprise Value | 416.75M |
| Earnings Yield | -26.99% |
| Normalized Earnings Yield | -13.87 |